Similar articles

• The management of febrile episodes in-neutropenic cancer.

  Bishop JF, McLennan R, Whiteside MG. Bishop JF, et al. Med J Aust. 1977 Apr 2;1(14):473-5. Med J Aust. 1977. PMID: 865367
• [Diagnosis and treatment of infection in the support of the neutropenic patient].

  Rafecas FJ, Sanz MA, Martín-Aragones G, Martínez JA, Sayas MJ, Marty ML. Rafecas FJ, et al. Sangre (Barc). 1985;30(4-B):501-14. Sangre (Barc). 1985. PMID: 4081964 Spanish. No abstract available.
• Management of infections in immunocompromised cancer patients.

  Bajetta E, Gasparini G, Monfardini S, Volonterio A, Buzzoni R, Shinde S. Bajetta E, et al. Haematologica. 1984 Sep-Oct;69(5):576-97. Haematologica. 1984. PMID: 6437936 Review. No abstract available.
• The febrile neutropenic patient: newer options for empirical therapy.

  Rubin M, Walsh T, Butler K, Lee J, Lecciones J, Weinberger M, Roilides E, Gress J, Marshall D, Pizzo PA. Rubin M, et al. Haematol Blood Transfus. 1990;33:531-8. doi: 10.1007/978-3-642-74643-7_95. Haematol Blood Transfus. 1990. PMID: 2157645 Review. No abstract available.
• Granulocyte transfusions as a therapy and a prophylaxis of infections in neutropenic patients.

  Klastersky J. Klastersky J. Eur J Cancer (1965). 1979;15 Suppl:15-22. Eur J Cancer (1965). 1979. PMID: 397059 Review. No abstract available.